Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.

导出 LinkOut

翻译打印收藏纠错

作者： Jingjing,Wen ^[1] ; Fang,Xu ^[1] ; Qiaolin,Zhou ^[1] ; Hong,Hu ^[1] ; Yiping,Liu ^[1] ; Jing,Su ^[1] ; Ya,Zhang ^[1] ; Wen,Qu ^[1] ; Lin,Shi ^[1]

作者单位： Department of Hematology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan 621000, P.R. China. ^[1]

关键词 APL WBC cytoreduction chemotherapy induction treatment initiation time low-intermediate risk multiplication rate

DOI 10.3892/mco.2021.2274

PMID 33903818

发布时间 2024-08-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular and clinical oncology

2021年14卷6期

112页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukemia with low-intermediate risk.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除